keep the enthusiasm in check
Yes we have had a great trial with the panc. But did anyone ever compare it to cornerstone pharmaceticals which had better results in their phase 1 trial than onc and then failed in their phase 3 trial. They actually had 3 cr's in their 20 patient orginal study, were allowed fast track but not AA....As Much as we all want this to work we need to understand that there is no guarantee and as much as I would like to see this partnered I would really prefer a buyout so as to not have to take a chance with the followup trial that might not prove out. I said before that 2 billion is reasonable considering all the risks that are still associated with future trials and really wonder if onc has ever been offered something similar and turned it down hoping for more. Just being a realist as the result and company comparisons so far are very similar.